브루커(BRKR) 주가 전망 및 기업 분석 - PER·배당·실적·목표주가·RSI·MACD

BRKR

Bruker Corp

7월 27일 4:00 PM ET (한국 7/28 05:00)

$60.01

-0.44 ▼ -0.73%

🌙 7월 27일 4:13 PM ET (한국 7/28 05:13)

$60.38

+0.33 ▲ +0.55%

브루커(BRKR) is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.

시가총액

$9.1B

스몰캡

P/E

배당수익률

0.33%

52주 위치

87%

저점 +110% · 고점 -7%

애널리스트

매수

B-

Fundamental health

vs. Medical Devices

수익성

Top 43%

성장

Top 55%

밸류에이션

Top 32%

재무 안정

Top 52%

💰 Is this stock pricier than usual right now?

Compared to this company's own recent 4년 (not other companies).

Very cheap

Cheap

Typical

Pricey

🔥 Very pricey

Simply put — what you pay today to own $1 of this company's yearly earnings is 59원. Over the past 4년, it usually traded around 34원. Earnings have also shrunk, which lifts the multiple — one of the priciest stretches of the past 4년.

Pricy doesn't mean bad — it means expectations are already baked in.· based on 4.2 profitable years

Index ⓘ	-	P/E ⓘ	-	EPS (ttm) ⓘ	-0.24	Insider Own ⓘ	27.01%	Shs Outstand ⓘ	152.2M	Perf Week ⓘ	6.84%
Market Cap ⓘ	9.14B	Forward P/E ⓘ	24.7	EPS next Y ⓘ	14.56%	Insider Trans ⓘ	-0.03%	Shs Float ⓘ	111.1M	Perf Month ⓘ	-1.45%
Enterprise Value ⓘ	10.73B	PEG ⓘ	1.57	EPS next Q ⓘ	0.38	Inst Own ⓘ	90.97%	Short Float ⓘ	13.17%	Perf Quarter ⓘ	64.19%
Income ⓘ	-0.04B	P/S ⓘ	2.64	EPS this Y ⓘ	15.87%	Inst Trans ⓘ	-0.23%	Short Ratio ⓘ	5.97	Perf Half Y ⓘ	19.23%
Sales ⓘ	3.46B	P/B ⓘ	3.73	EPS next 5Y ⓘ	15.76%	ROA ⓘ	-0.19%	Short Interest ⓘ	14.63M	Perf YTD ⓘ	27.38%
Book/sh ⓘ	16.09	P/C ⓘ	68.48	EPS past 3/5Y ⓘ	-	ROE ⓘ	-0.54%	52W High ⓘ	-7.02% ($64.54)	Perf Year ⓘ	43.09%
Cash/sh ⓘ	0.88	P/FCF ⓘ	178.07	Sales past 3/5Y ⓘ	10.74% 11.57%	ROIC ⓘ	-0.28%	52W Low ⓘ	110.34% ($28.53)	Perf 3Y ⓘ	-14.11%
Dividend Est. ⓘ	$0.2 (0.33%)	EV/EBITDA ⓘ	22.67	EPS Y/Y TTM ⓘ	-145.55%	Gross Margin ⓘ	46.29%	Volatility(W/M) ⓘ	5.61% 4.47%	Perf 5Y ⓘ	-25.72%
Dividend TTM ⓘ	0.2	EV/Sales ⓘ	3.1	Sales Y/Y TTM ⓘ	0.36%	Oper. Margin ⓘ	7.08%	ATR (14) ⓘ	2.78	Perf 10Y ⓘ	145.84%
Dividend Ex-Date ⓘ	2026/6/22	Quick Ratio ⓘ	0.72	EPS Q/Q ⓘ	-80.02%	Profit Margin ⓘ	-1.05%	RSI (14) ⓘ	54.02	Recom ⓘ	2
Dividend Gr. 3/5Y ⓘ	- 4.56%	Current Ratio ⓘ	1.55	Sales Q/Q ⓘ	2.75%	SMA20 ⓘ	0.56% ($59.68)	Beta ⓘ	1.28	Target Price ⓘ	$59.75
Payout ⓘ	-	Debt/Eq ⓘ	0.68	Earnings ⓘ	2026/8/4	SMA50 ⓘ	7.22% ($55.97)	Rel Volume ⓘ	0.75	Prev Close ⓘ	$60.45
Employees ⓘ	11085	LT Debt/Eq ⓘ	0.68	EPS/Sales Surpr. ⓘ	35.14% 3.49%	SMA200 ⓘ	32.68% ($45.23)	Avg Volume(3M) ⓘ	2.45M	Price ⓘ	$60.01
IPO ⓘ	2000/8/4	Option/Short ⓘ	Yes/Yes			Trades ⓘ	16489	Volume ⓘ	1,840,984	Change ⓘ	-0.73%

Quarterly earnings trend SEC filings · USD

24.6

24.9

24.12*

25.3

25.6

25.9

25.12*

26.3

Revenue Net income 최근 분기: 매출 $823M (YoY +3%) · 순이익 $14M (YoY -17%)

* Q4 figures are derived from the annual filing (10-K) · loss-making quarters are underlined in red

📊 Bruker Corp (BRKR) Investment Analysis

What kind of company is Bruker Corp?

브루커(BRKR) 성장주

Healthcare · Medical Devices

#998 by Market Cap — Mid-Cap

A U.S. scientific instrumentation company that supplies advanced analytical and research equipment, such as mass spectrometers and nuclear magnetic resonance systems, to pharmaceutical, biotech, and research institutions. Its performance is largely driven by research and development demand, along with recurring revenue from consumables and services.

Learn more about Bruker Corp →

Market Cap

$9.1B

Approx. KRW 12.5 trillion

⚖️ 3% of Samsung Electronics

Market Cap Rank998

Employees11,085people

IPO2000/08/04

Current Price$60.01 ≈ 82,214원

NASD · USA

Key Events

⏰ Upcoming events

🔔 Earnings release D-8

8월 4일 (화) · 장 시작 전

🎯 Ex-dividend date

No scheduled dividends

📜 Recent events

🎯 Ex-div 2026년 6월 22일 (월) 주당 $0.33

🔔 Earnings release 2026년 5월 6일 (수) · 장 시작 전 EPS +35.1% 매출 +3.5%

🎯 Ex-div 2026년 3월 23일 (월) 주당 $0.05

🔔 Earnings release 2026년 2월 12일 (목) · 장 시작 전 EPS -9.3% 매출 +1.6%

Is it profitable?

Profitability weak

Profitability — How efficiently it makes money

Operating Margin

Profit kept from selling products and services (higher is better)

7.1%

✓ 양호

My positionMid-range

Low range Average High range

Medical Devices Median -23.9% · Top 25%

💡 일반적으로 10% 이상이면 양호, 20% 이상이면 우수

Net Margin

Share of revenue left after taxes and interest are paid

-1.1%

✓ 적자

💡 적자 상태 — 수익을 내지 못하고 있습니다

Gross Margin

Profit after subtracting raw-material costs only (signals product competitiveness)

46.3%

✓ 평균

My positionMid-range

Low range Average High range

Medical Devices Median 54.4% · Bottom 38%

💡 제조업 30%, IT/소프트웨어 50% 이상이면 우수 (업종별 편차 큼)

ROE

Annual return earned on shareholders' equity (15%+ is strong)

-0.5%

✓ 적자

💡 적자 상태 — 수익을 내지 못하고 있습니다

ROA

Annual earnings relative to total company assets

-0.2%

✓ 적자

💡 적자 상태 — 수익을 내지 못하고 있습니다

ROIC

Return generated per dollar invested in the business

-0.3%

✓ 적자

💡 적자 상태 — 수익을 내지 못하고 있습니다

Financial health — Debt & liquidity burden

Debt-to-Equity (D/E)

Debt relative to equity (lower is healthier)

0.68

✓ Average

My positionMid-range

Low range Average High range

Medical Devices Median 0.39

💡 일반적으로 1.0 이하면 건전, 1.5까지는 무난 (금융·유틸·REIT는 구조적으로 높음)

Current Ratio

Liquid assets available to cover liabilities due within a year

1.55

✓ 양호

My positionMid-range

Low range Average High range

Medical Devices Median 2.91

💡 1.5~3.0 적정, 1.0 미만이면 단기 유동성 주의

Quick Ratio

Liquid assets excluding inventory, available for immediate use

0.72

✓ 평균

My positionMid-range

Low range Average High range

Medical Devices Median 2.09

💡 1.0 이상이면 안전, 0.5 미만이면 주의

* Ratings reflect relative position vs. peer-group distribution (same sector & size) plus absolute guards (loss & risk thresholds).

What's the outlook?

Mixed Outlook

Positive and negative signals are mixed

애널리스트 목표가

$59.75

현재가 대비 -0.4%

💡 12개월 이내 도달을 전망하는 애널리스트 컨센서스 평균

예상 PER (Forward)

24.70배

💡 내년 예상 EPS 기준. 현재 PER과 비교해 이익 성장 반영 정도 확인

PEG (성장 반영 밸류)

1.57

다소 비쌈

💡 PEG 1.5~2 — 성장 대비 다소 비쌈

내년 EPS 예상 성장률

+14.6%

💡 10% 이상이면 견조한 성장, 마이너스는 이익 감소 예상

5년 EPS 예상 연평균

+15.8%

💡 장기 성장 전망. 15% 이상이면 고성장 기업

⚠ 이 데이터는 애널리스트 추정치이며 실제 결과와 다를 수 있습니다. 투자 결정은 추가 검토와 함께 하세요.

Did earnings meet expectations?

Average Earnings Performance

Mixed beats and misses

예상 상회

예상 부합

예상 하회

50%

상회 비율

+12.5%

평균 서프라이즈

2026.05.06

상회

실적 $0.31 · 예상 $0.23 +34.8%

2026.02.12

하회

실적 $0.59 · 예상 $0.65 -9.8%

💡 예상보다 높은 실적을 자주 내는 기업은 실적 신뢰도가 높다고 평가됩니다. 단, 애널리스트 기대치가 낮게 설정되었을 수도 있으니 절대 수치도 함께 봐야 합니다.

Is it growing?

Average Growth

Mid-range within the industry

🔮 How much will it grow? (analyst forecasts)

This Year's EPS Outlook

Projected EPS growth rate for this year

+15.9%

양호

My positionMid-range

Low range Average High range

성장주 중형주 Median 13.7% · Top 44%

Next Year's EPS Outlook

Projected EPS growth rate for next year (analyst consensus)

+14.6%

평균

My positionMid-range

Low range Average High range

성장주 중형주 Median 15.1% · Bottom 47%

5-Year EPS CAGR Outlook

Projected average annual EPS growth over the next 5 years

+15.8%

평균

My positionMid-range

Low range Average High range

성장주 중형주 Median 15.9% · Bottom 49%

📊 How much has it grown? (actual results)

Past 5-Year Revenue

How much revenue grew over the past 5 years

+11.6%

양호

My positionMid-range

Low range Average High range

성장주 중형주 Median 10.6% · Top 46%

⚡ Short-term momentum

QoQ Revenue

Revenue change from the previous quarter (short-term momentum)

+2.8%

부진

My positionBottom 25%

Low range Average High range

성장주 중형주 Median 11.1% · Bottom 20%

* Forecast values are analyst consensus estimates. Ratings are determined by relative position vs. peer group of the same growth style and size.

New to investing terms? Look it up in the financial dictionary →

Has the stock risen over the long term?

Long-term weakness — -94%p below the market

BRKR -25.7% · S&P 500 +68.3%

Excess return vs. market (price-based, ex-dividends)

5-year basis

vs S&P 500

-94.1%p

Significantly behind the market

vs Health Care (XLV)

-50.2%p

Significantly behind the sector average

1-year basis

vs S&P 500

+27.1%p

ahead of the market

vs Health Care (XLV)

+23.4%p

ahead of the sector average

Rank among peers

5-year return Bottom 21% Based on 11 peers

1-year return Lower-Mid (lower 47%) Based on 11 peers

Current position within 52-week range

Low (-110.3%p) High (-7.0%p)

Current price is 110.3% above the 52-week low and 7.0% below the 52-week high

Recent risk (last 120 trading days)

Max drawdown

-23.0%

Annualized volatility

56.3%

Technical Indicators

Bollinger Bands · MACD · RSI · Stochastics · Ichimoku 5-line · recent 137-day series

Price · Bollinger Bands · Ichimoku Cloud

close
BB Upper
BB Mid
BB Lower
Tenkan
Kijun
Cloud (SpanA/B)

Bollinger Bands are upper and lower channels showing the closing price range (20 days · 2σ). Touching the upper band = overheated; touching the lower band = oversold. Ichimoku Cloud shows trend direction and strength through colored areas. Prices above the cloud indicate an uptrend; prices below indicate a downtrend. About Bollinger Bands →

🟢

Current diagnosis · 2026-07-27

Uptrend zone

Current price $60.01 above the midline ($59.67). Normal upward flow. Above the Ichimoku cloud (bullish).

MACD (12 · 26 · 9) Expand ▼

An indicator that uses the difference between the short-term EMA (12) and long-term EMA (26) to identify trend reversals. When MACD rises above the Signal line, it is a buy signal (golden cross); when it falls below, it is a sell signal (death cross). About MACD →

🟡

Current diagnosis · 2026-07-27

Neutral zone — weak trend

MACD 1.162 · Signal 1.355 · Hist -0.194. Weak directional bias.

RSI(14) · Stochastics %K(14) Expand ▼

RSI measures short-term buying and selling pressure on a scale of 0–100. 30 or below = oversold (a rebound may be possible); 70 or above = overbought (a pullback may be possible). Stoch %K similarly measures short-term momentum strength. RSI · Learn more about Stochastics →

🟢

Current diagnosis · 2026-07-27

Bullish zone

RSI 54.0 (above the neutral level of 50). Buying pressure leads, supporting a steady rise. Stoch %K is also 60.0.

※ "Current diagnosis" is an automated interpretation based on standard thresholds and is for reference only. Make your own comprehensive judgment before trading.

Is it attractive at this price?

In line with the industry average

Cheap on Vs. Sales, Pricey on Vs. Cash Flow, In line with peers on Vs. Earnings·Vs. Assets

💡 How to read this — Compare against peers in the same industry to see what the price is cheap or expensive relative to. Example: cheap vs. earnings = stock price is low relative to what the company earns; expensive vs. assets = stock price is high relative to assets on the balance sheet.

💵 Vs. Earnings Mid-range

🏢 Vs. Assets Mid-range

🧾 Vs. Sales Cheap

💧 Vs. Cash Flow Pricey

💵 Vs. Earnings

Forward PER Forward Price-to-Earnings Ratio

PER using next year's estimated earnings — reflects growth

24.70x

✓ Fair

My positionMid-range

Low range Average High range

Medical Devices median 17.57x · Around the industry average

💡 향후 12개월 예상 EPS 기준 PER. 현재 PER보다 낮으면 이익 성장 중

🏢 Vs. Assets

PBR Price-to-Book Ratio

Price vs. the company's asset value — below 1 trades cheaper than assets

3.73x

✓ Fair

My positionMid-range

Low range Average High range

Medical Devices median 2.58x · Around the industry average

💡 PBR 1 미만이면 청산가치 이하 (금융·제조업에서 특히 의미, IT는 낮은 비중)

🧾 Vs. Sales

PSR Price-to-Sales Ratio

Market cap vs. revenue — lower is cheaper relative to sales

2.64x

✓ Cheap

My positionMid-range

Low range Average High range

Medical Devices median 2.64x · Around the industry average

💡 PSR 2 이하 저평가, 10 초과면 고평가 (고성장 기업일 때만 정당화)

💧 Vs. Cash Flow

EV/EBITDA Enterprise Value Multiple

Total enterprise value ÷ operating cash earnings — a benchmark for M&A

22.67x

✓ Pricey

My positionBottom 25%

Low range Average High range

Medical Devices median 14.42x · Bottom 24% — expensive within the industry

💡 EV/EBITDA 10 이하 저평가, 20 이상이면 고평가 (M&A 밸류 기준)

💧 Vs. Cash Flow

P/FCF Price-to-Free-Cash-Flow Ratio

Price vs. actual cash generation — lower means more efficient

178.07x

✓ Pricey

My positionBottom 25%

Low range Average High range

Medical Devices median 21.45x · Bottom 10% — expensive within the industry

💡 P/FCF 20 이하면 현금창출 대비 저평가 (실질 수익성 기준)

Analyst target price (reference)

$59.75 vs. current price -0.4%

* Valuation is the stock's relative position within the industry peer group (same sector and market-cap range). Even when valuation looks attractive, check the 'Profitability' and 'Growth' sections too.

As of: Recent snapshot · Peer group: Medical Devices

Who owns it?

Ownership backdrop is unfavorable

Insider modest net selling -0.0% · Institutional modest net selling -0.2% · Short interest elevated 13.2% · Short interest up +3.1pp over last 90d

📈 Recent trading flow (6 months)

🧑‍💼 Insiders (executives & directors)

-0.0%

Insiders little change

🏦 Institutions (funds & investors)

-0.2%

Institutions net selling

💡 Net change over the past 6 months. Shows how much insiders and institutions increased or reduced their holdings, in %.

👥 Holdings composition

🏦 Institutions 91.0%

Institution-led, stable structure

Healthcare 중형주 Median 89.4%

🧑‍💼 Insiders 27.0%

Founder/management large holders (strong skin-in-the-game)

Healthcare 중형주 Median 9.4%

👤 Retail investors (estimated) 0.0%

Everyone excluding institutions and insiders

Institutions Insiders Retail (est.)

📉 Short-selling metrics

Short ratio

13.2%

Somewhat high

Healthcare 중형주 Median 11.3%

Past 90 days 📈 +3.1%p increase

Short interest days to cover

6.0 days

Days needed to close short positions using average trading volume

🧮 Share count

Total shares outstanding 152.2M주

Float (tradable shares) 111.1M주

* Insider/institutional flows are based on net changes over the past 6 months. Trend is cumulative over the past 90 days.

ETFs holding BRKR

ETFs with the highest weightings · 10 total shown

TINY

ProShares Nanotechnology ETF

3.54%

$22M

FBT

First Trust NYSE Arca Biotechnology Index Fund

2.36%

$2.8B

SPFF

Global X SuperIncome Preferred ETF

2.08%

$139M

MGMT

Ballast Small/Mid Cap ETF

1.36%

$174M

TSCV

Thrivent Small Cap Value ETF

1.14%

$184M

* Based on official quarterly filings. Latest disclosure; actual current weights may differ.

How much does it pay in dividends?

배당 지급 — 연 0.33%

배당보다 주가 성장에 가까운 비중

Dividend Yield

0.33%

Industry average 1.23%

Dividend Per Share

$0.20

Annualized

Payout Ratio

Share of net income paid as dividends

5-Year Growth

4.6%

Annualized dividend growth

📅 지급월 3월 · 9월 · 12월

📊 총 이력 2016~2026 (41건)

연도별 배당 총액 추이

주당 배당금을 연 단위로 합산한 금액입니다. 막대가 우상향이면 매년 배당이 늘어나고 있다는 뜻입니다.

$0.16

2016

$0.16 +0.0%

2017

$0.16 +0.0%

2018

$0.16 +0.0%

2019

$0.16 +0.0%

2020

$0.16 +0.0%

2021

$0.20 +25.0%

2022

$0.20 +0.0%

2023

$0.20 +0.0%

2024

$0.20 +0.0%

2025

$X.XX 그 해 총 배당금 +X% 전년 대비 증가 -X% 감소

최근 배당 이력 총 41건

아래로 스크롤하면 과거 배당 이력을 볼 수 있습니다.

배당락일

주당 금액

지급일

당시 수익률

2026-03-23

$0.050

—

0.57%

2025-12-08

$0.050

—

0.43%

2025-09-23

$0.050

—

0.60%

2025-06-16

$0.050

—

0.51%

2025-03-17

$0.050

—

0.43%

2024-12-02

$0.050

—

0.34%

2024-08-30

$0.050

—

0.37%

2024-06-03

$0.050

—

0.31%

2024-02-29

$0.050

—

0.23%

2023-11-30

$0.050

—

0.38%

2023-08-31

$0.050

—

0.38%

2023-05-31

$0.050

—

0.36%

2023-02-28

$0.050

—

0.36%

2022-11-30

$0.050

—

0.36%

2022-08-31

$0.050

—

0.41%

2022-05-31

$0.050

—

0.29%

2022-02-28

$0.050

—

0.30%

2021-11-30

$0.040

—

0.25%

2021-08-31

$0.040

—

0.23%

2021-05-28

$0.040

—

0.29%

2021-03-04

$0.040

—

0.34%

2020-11-30

$0.040

—

0.32%

2020-08-31

$0.040

—

0.38%

2020-05-29

$0.040

—

0.46%

2020-03-06

$0.040

—

0.36%

2019-11-29

$0.040

—

0.39%

2019-08-30

$0.040

—

0.46%

2019-05-31

$0.040

—

0.48%

2019-03-04

$0.040

—

0.52%

2018-11-30

$0.040

—

0.60%

2018-08-31

$0.040

—

0.56%

2018-06-01

$0.040

—

0.66%

2018-03-05

$0.040

—

0.67%

2017-12-01

$0.040

—

0.57%

2017-08-31

$0.040

—

0.69%

2017-06-01

$0.040

—

0.73%

2017-03-06

$0.040

—

0.67%

2016-12-01

$0.040

—

0.71%

2016-09-01

$0.040

—

0.53%

2016-06-02

$0.040

—

0.30%

2016-03-02

$0.040

—

0.14%

* "배당락일"은 배당받으려면 이 날 이전에 주식을 보유해야 하는 기준일입니다. 지급일·당시 수익률은 일부 종목에서 데이터가 없을 수 있습니다.

💰 내가 100만원 투자한다면

연간 배당금 (세후) 2,833원

5년 누적 (세후) 1.6만원

* 환율 1,370원, 세금 15% 반영. 5년 누적은 배당 성장률 연 4.56% 가정.

Compare Industry Peers

💡 vs. sector average ▲ Favorable / ▼ Unfavorable (Lower PER and PBR are better; higher ROE and dividend yield are better)

Sorted by market cap, largest first

Stock	Market Cap	PER	PBR	ROE	Dividend Yield	Change
BRKR This Stock	$9.1B	-	3.7 ▼	-0.54% ▲	0.33% ▼	-0.7%
LLY	$1.13T	43.1 ▼	36.2 ▼	107.64% ▲	0.58% ▼	+0.1%
JNJ	$640.9B	30.8 ▼	7.5 ▼	25.74% ▲	2.02% ▲	+1.0%
ABBV	$453.9B	126.7 ▼	-	15221.82% ▲	2.67% ▲	-0.9%
UNH	$379.3B	26.9 ▼	3.9 ▼	12.49% ▲	2.16% ▲	-0.7%
MRK	$323.0B	36.8 ▼	7.0 ▼	18.97% ▲	2.5% ▲	-0.2%
Sector Avg	-	26.1	2.7	-48.83%	1.23%	-

FAQ

What kind of company is 브루커(BRKR)?

브루커(BRKR) belongs to the Healthcare sector and operates in the Medical Devices industry.

What is the market cap of BRKR?

The market cap of BRKR is approximately $9.1B, ranking 998 within its sector.

Does BRKR pay dividends?

BRKR has a dividend yield of approximately 0.33%, with an annual dividend of $0.20.

What is the 52-week high and low for BRKR?

BRKR has recorded a 52-week high of $64.54 and a low of $28.53.

면책조항: 본 콘텐츠는 참고 자료이며 투자 권유가 아닙니다. 모든 투자의 책임은 투자자 본인에게 있습니다.